JPWO2023150698A5 - - Google Patents
Info
- Publication number
- JPWO2023150698A5 JPWO2023150698A5 JP2024545105A JP2024545105A JPWO2023150698A5 JP WO2023150698 A5 JPWO2023150698 A5 JP WO2023150698A5 JP 2024545105 A JP2024545105 A JP 2024545105A JP 2024545105 A JP2024545105 A JP 2024545105A JP WO2023150698 A5 JPWO2023150698 A5 JP WO2023150698A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- receptor protein
- chimeric receptor
- cell
- genetically modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306514P | 2022-02-04 | 2022-02-04 | |
| US63/306,514 | 2022-02-04 | ||
| PCT/US2023/061966 WO2023150698A2 (en) | 2022-02-04 | 2023-02-03 | Chimeric ilt receptor compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025505546A JP2025505546A (ja) | 2025-02-28 |
| JP2025505546A5 JP2025505546A5 (https=) | 2026-02-10 |
| JPWO2023150698A5 true JPWO2023150698A5 (https=) | 2026-02-10 |
Family
ID=87553009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545105A Pending JP2025505546A (ja) | 2022-02-04 | 2023-02-03 | キメラｉｌｔ受容体組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12269861B2 (https=) |
| EP (1) | EP4473006A4 (https=) |
| JP (1) | JP2025505546A (https=) |
| KR (1) | KR20240156654A (https=) |
| CN (1) | CN119053618A (https=) |
| AU (1) | AU2023216270A1 (https=) |
| CA (1) | CA3248806A1 (https=) |
| WO (1) | WO2023150698A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119569893B (zh) * | 2023-09-06 | 2025-10-31 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤的嵌合抗原受体细胞及其制备方法和应用 |
| CN119569892A (zh) * | 2023-09-06 | 2025-03-07 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤非经典hla分子的嵌合抗原受体的应用 |
| CN119569891B (zh) * | 2023-09-06 | 2025-09-05 | 上海恩凯细胞技术有限公司 | 用于癌症治疗的靶向非经典hla分子的嵌合抗原受体的应用 |
| CN120248130A (zh) * | 2023-12-28 | 2025-07-04 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤的转基因重组免疫细胞及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201206559D0 (en) * | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| EP2730588A1 (en) | 2012-11-12 | 2014-05-14 | Intelectys | Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof |
| EP3209769B1 (en) * | 2014-10-24 | 2020-08-05 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance |
| NZ748929A (en) | 2016-06-03 | 2025-11-28 | Invectys | Anti hla-g specific antibodies |
| KR20180064612A (ko) * | 2016-12-05 | 2018-06-15 | 삼성디스플레이 주식회사 | 표시 장치 |
| AU2019328677A1 (en) | 2018-08-31 | 2021-04-01 | Invectys SA | Chimeric antigen receptors against multiple HLA-G isoforms |
| US20200190163A1 (en) * | 2018-10-26 | 2020-06-18 | Lijun Wu | Humanized bcma-car-t cells |
| IL285909B2 (en) * | 2019-03-15 | 2023-04-01 | Cartesian Therapeutics Inc | Single-stranded variable segments directed against bcma |
| JP7739261B2 (ja) | 2019-08-09 | 2025-09-16 | エイ２・バイオセラピューティクス・インコーポレイテッド | ヘテロ接合性の喪失に応答する細胞表面受容体 |
-
2023
- 2023-02-03 CN CN202380026753.7A patent/CN119053618A/zh active Pending
- 2023-02-03 CA CA3248806A patent/CA3248806A1/en active Pending
- 2023-02-03 KR KR1020247029752A patent/KR20240156654A/ko active Pending
- 2023-02-03 WO PCT/US2023/061966 patent/WO2023150698A2/en not_active Ceased
- 2023-02-03 AU AU2023216270A patent/AU2023216270A1/en active Pending
- 2023-02-03 JP JP2024545105A patent/JP2025505546A/ja active Pending
- 2023-02-03 US US18/164,417 patent/US12269861B2/en active Active
- 2023-02-03 EP EP23750451.9A patent/EP4473006A4/en active Pending
-
2025
- 2025-02-28 US US19/067,503 patent/US20250257114A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3472205B1 (en) | Chimeric antigen receptor | |
| Pende et al. | The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. | |
| CN112074279A (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| KR20230095083A (ko) | Cd7 표적의 키메라 항원 수용체 및 이의 용도 | |
| JP2021512615A5 (https=) | ||
| JP2021522844A (ja) | キメラ抗原受容体 | |
| KR20180054713A (ko) | 조율가능한 변종 면역글로불린 수퍼패밀리 도메인 및 유전자 조작된 세포 치료법 | |
| KR20170092695A (ko) | 세포 | |
| KR102475696B1 (ko) | 키메라 폴리펩티드 및 그의 세포 막 내 국재화를 변경시키는 방법 | |
| CN111542545A (zh) | Cd38定向嵌合抗原受体构建体 | |
| JP2021532742A5 (https=) | ||
| CA3019509A1 (en) | Inhibition of tgfbeta in immunotherapy | |
| US12269861B2 (en) | Chimeric ILT receptor compositions and methods | |
| CN114957481A (zh) | 针对cd19和cd22的双靶点star | |
| WO2020160419A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
| JPWO2019155288A5 (https=) | ||
| JPWO2023150698A5 (https=) | ||
| CA3231382A1 (en) | Binding domain | |
| EP2167538A2 (en) | Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof | |
| CN113271965B (zh) | Cd37抗体和cd37-car-t细胞 | |
| KR20230061486A (ko) | 면역 세포 내 어댑터의 유도성 발현을 위한 시스템 | |
| CN114286691A (zh) | Cs1-抗体和抗cs1-car-t细胞 | |
| JPWO2021037222A5 (https=) | ||
| TW202346359A (zh) | 用於治療自體免疫疾病之方法及組合物 | |
| JPWO2022043483A5 (https=) |